Antibody formulation

The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent.

Saved in:
Bibliographic Details
Main Authors Dunleavy, Donna M, Marshall, Tristan, O'Berry, Kristen, Perkins, Melissa D, Puri, Manasi, Blake-Haskins, Angela, Crotts, George H
Format Patent
LanguageEnglish
Published 24.11.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent.
Bibliography:Application Number: AU20150260758